Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Pathogenic germline mutations prevalence in Saudi patients with pancreatic ductal adenocarcinoma.
Authors
Mohammed Ahmed Algarni
King Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
Mohammed Ahmed Algarni , Kanan Alshammari , Ashwaq Al Olayan , Fouad Sabatin , Nadine Mabsout , Horya Zaher , Husam Shehata , Saeed Al Turki
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Prevention, Screening, and Hereditary Cancers
DOI
10.1200/JCO.2022.40.4_suppl.538
Abstract #
538
Poster Bd #
F7
Abstract Disclosures
Similar Posters
First Author: Krystal Brown
Poster
2023 ASCO Annual Meeting
Somatic profiling guides germline genetic testing in patients with mutations in cancer predisposition genes.
First Author: Sourat Darabi
Poster
2023 ASCO Genitourinary Cancers Symposium
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
First Author: Channing Judith Paller
Poster
2022 ASCO Genitourinary Cancers Symposium
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
First Author: Channing Judith Paller